| Methods for treating chronic obstructive pulmonary disease |
2022-9-26 |
2023-4-06 |
|
| Dimethyl amino azetidine amides as jak inhibitors |
2022-9-06 |
2022-11-15 |
|
| Crystalline hydrate of a jak inhibitor compound |
2022-8-31 |
2022-9-20 |
|
| Methods of treating symptoms of gastroparesis using velusetrag |
2022-8-26 |
2022-11-09 |
|
| Jak inhibitors containing a 4-membered heterocyclic amide |
2022-8-10 |
2023-3-02 |
|
| Pyrimidine compound as jak kinase inhibitor |
2022-6-30 |
2022-12-15 |
|
| Imidazolo indazole compounds as jak inhibitors |
2022-6-24 |
2022-12-29 |
|
| Method of treating a patient infected with a coronavirus and having a baseline … |
2022-6-20 |
2022-12-29 |
|
| Crystalline forms of a biphenyl compound |
2022-6-17 |
2022-12-08 |
|
| Methods of treatment using jak inhibitor compound |
2022-6-15 |
2022-8-17 |
|
| Crystalline freebase forms of a biphenyl compound |
2022-6-15 |
2022-9-29 |
|
| Bicyclic inhibitors of alk5 and methods of use |
2022-5-25 |
2022-12-01 |
|
| Substituted 1,5-naphthyridines or quinolines as alk5 inhibitors |
2022-5-17 |
2022-7-01 |
|
| Enantioselective synthesis of aminotropane compound |
2022-5-13 |
2022-11-17 |
|
| Crystalline form of a dihydrochloride salt of a jak inhibitor compound |
2022-3-25 |
2022-9-29 |
|
| Jak kinase inhibitor compounds for treatment of respiratory disease |
2022-3-07 |
2022-9-29 |
|
| Amino amide tetrahydro imidazo pyridines as jak inhibitors |
2022-2-18 |
2022-8-25 |
|
| Neprilysin inhibitors |
2022-1-19 |
2022-9-22 |
|
| Benzimidazole-carboxamide compounds as 5-ht4 receptor agonists |
2022-1-12 |
2022-9-01 |
|
| Biphenyl compounds useful as muscarinic receptor antagonists |
2022-1-05 |
2022-9-29 |
|
| Crystalline (2s,4r)-5-(5'-chloro-2'-fluoro-[1,1'-biphenyl]-4-yl)-2-( … |
2021-12-14 |
2022-8-04 |
|
| Compound for use in the treatment of neurogenic orthostatic hypotension |
2021-11-17 |
2022-1-01 |
|
| FORMULATION OF A PAN-JAK INHIBITOR |
2021-10-07 |
2022-4-29 |
|
| Processes for preparing a pan-jak inhibitor and related intermediate compounds |
2021-10-07 |
2022-4-14 |
|
| Fused imidazo-piperidine jak inhibitor compound |
2021-9-28 |
2022-1-13 |
|
| Ester and carbonate pyrimidine compounds as jak kinase inhibitors |
2021-9-27 |
2022-1-13 |
|
| Neprilysin inhibitors |
2021-8-16 |
2022-4-07 |
|
| Naphthyridine and quinoline derivatives useful as alk5 inhibitors |
2021-6-11 |
2021-9-20 |
|
| Crystalline alk5 inhibitors and uses thereof |
2021-6-09 |
2022-4-16 |
|
| CRYSTALLINE ALK5 INHIBITORS AND USES OF THESE |
2021-6-09 |
2022-9-21 |
|
| (2r,4r)-5-(5'-chloro-2'-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2- … |
2021-5-14 |
2021-12-30 |
|
| Administration of gut-selective jak3 inhibitor |
2021-5-10 |
2021-11-18 |
|
| Method of treating a patient infected with a coronavirus with nezulcitinib |
2021-5-07 |
2021-11-11 |
|
| 2-azabicyclo hexane compound as jak inhibitor |
2021-4-20 |
2021-6-30 |
|
| Substituted pyrimidines and methods of use |
2021-3-30 |
2022-12-06 |
|
| SUBSTITUTED PYRIMIDINES AS ALK5 INHIBITORS |
2021-3-30 |
2022-6-29 |
|
| Naphthyridine compounds as jak kinase inhibitors |
2021-3-22 |
2021-7-01 |
|
| Pyrazolo and triazolo bicyclic compounds as jak kinase inhibitors |
2021-3-17 |
2021-7-01 |
|
| 5- to 7-membered heterocyclic amides as jak inhibitors |
2021-3-04 |
2021-5-31 |
|
| Process for preparing jak inhibitors and intermediates thereof |
2021-2-28 |
2021-4-29 |
|
| Prodrugs of a JAK inhibitor compound for treatment of gastrointestinal … |
2021-2-22 |
2023-3-21 |
2023-3-21 |
| Combination dosage form of a mu opioid receptor antagonist and an opioid agent |
2021-2-08 |
2022-9-27 |
2022-9-27 |
| Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound |
2021-2-05 |
2023-3-07 |
2023-3-07 |
| Fused pyrimidine pyridinone compounds as jak inhibitors |
2020-11-24 |
2021-6-03 |
|
| SUBSTITUTED PYRIDINES AND METHODS OF USE |
2020-11-20 |
2022-2-23 |
|
| Imidazole and triazole containing bicyclic compounds as jak inhibitors |
2020-10-23 |
2021-2-11 |
|
| Neprilysin inhibitors |
2020-10-05 |
2021-5-27 |
|
| Glucuronide prodrugs of janus kinase inhibitors |
2020-7-13 |
2021-2-04 |
|
| (2s,4r)-5-(5'-chloro-2'-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2- … |
2020-7-09 |
2020-11-05 |
|
| Neprilysin inhibitors |
2020-7-08 |
2023-1-10 |
2023-1-10 |
| 8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists |
2020-7-07 |
2023-1-10 |
2023-1-10 |
| Pyrimidine jak inhibitors for the treatment of skin diseases |
2020-4-23 |
2022-3-02 |
|
| Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 Adrenergic … |
2020-1-28 |
2020-5-28 |
|
| ALK5 INHIBITORS |
2019-12-10 |
2021-7-28 |
|
| Crystalline forms of a jak inhibitor compound |
2019-10-25 |
2020-6-29 |
|
| Pyrimidine compounds as JAK kinase inhibitors |
2019-10-18 |
2021-9-07 |
2021-9-07 |
| Naphthyridine compounds as jak kinase inhibitors |
2019-10-15 |
2019-12-27 |
|
| Dimethyl amino azetidine amides and 5 to 7 membered heterocyclic amides as jak … |
2019-9-03 |
2020-3-04 |
|
| PROCESS FOR THE PREPARATION OF 2- (1- (TERT-BUTOXYLCARBONYL) -PIPERIDINE-4-YL) … |
2019-5-29 |
2021-3-03 |
|
| Pyrimidine compound as JAK kinase inhibitor. |
2018-10-26 |
2021-7-14 |
|
| 5-biphenyl-4-heteroarylcarbonylamino-pentanoic acid derivatives as neprilysin … |
2018-8-31 |
2018-12-20 |
|
| Neprilysin inhibitors |
2018-8-31 |
2018-12-20 |
|
| Neprilysin inhibitors |
2018-8-31 |
2018-12-27 |
|
| Hydrochloride of antibiotic compound |
2018-8-17 |
2018-11-15 |
|
| Crystalline form of a substituted thiazolylacetic acid triethylamine salt |
2018-8-15 |
2018-12-13 |
|
| Thiocarbamate prodrugs of tofacitinib |
2018-5-22 |
2020-1-07 |
|
| Methods of treatment using JAK inhibitor compounds |
2018-4-30 |
2023-4-04 |
2023-4-04 |
| Methods of treatment using a jak inhibitor compound |
2018-4-30 |
2022-1-06 |
|
| Doses and methods for administering telavancin |
2018-4-04 |
2020-8-25 |
2020-8-25 |
| Crystalline forms of an 8-azabicyclo[3.2.1]octane compound |
2018-3-13 |
2019-10-01 |
2019-10-01 |
| Jak inhibitors containing a 4-membered heterocyclic amide |
2018-3-08 |
2021-8-03 |
|
| Glucuronide prodrugs of tofacitinib |
2018-3-07 |
2019-11-12 |
2019-11-12 |
| CONNECTORS OF 5-HT4 CONCENTRATORS AND ACTHYLCHOLINESTERATION INHIBITORS FOR … |
2018-1-19 |
2018-6-27 |
|
| CRYSTAL FORM OF A QUINOLINONA-CARBOXAMIDA COMPOUND |
2017-11-01 |
2019-2-13 |
|
| Neprilysin inhibitors |
2017-10-24 |
2018-7-12 |
|
| Diamide compounds having muscarinic receptor antagonist and beta2 adrenergic … |
2017-9-26 |
2017-10-19 |
|
| 使用jak抑制剂化合物的治疗方法 |
2018-4-30 |
2023-4-04 |
2023-4-04 |